login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
VERA THERAPEUTICS INC (VERA) Stock News
USA
- NASDAQ:VERA -
US92337R1014
-
Common Stock
23.77
USD
-0.76 (-3.1%)
Last: 9/12/2025, 8:23:29 PM
23.77
USD
0 (0%)
After Hours:
9/12/2025, 8:23:29 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VERA Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: Vera Therapeutics
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9 days ago - By: Vera Therapeutics
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 days ago - By: Vera Therapeutics
Vera Therapeutics to Participate at Upcoming Investor Conferences
19 days ago - By: Vera Therapeutics
Vera Therapeutics to Participate at Upcoming Investor Conferences
a month ago - By: The Motley Fool
Vera (VERA) Q2 Net Loss Widens 127%
a month ago - By: Vera Therapeutics
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: Vera Therapeutics
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - By: Vera Therapeutics
Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
a month ago - By: Vera Therapeutics
Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
a month ago - By: Benzinga
- Mentions:
AVB
ALLO
SHEL
This AvalonBay Communities Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday
2 months ago - By: Benzinga
- Mentions:
SRPT
RDHL
MESO
WINT
...
12 Health Care Stocks Moving In Friday's Pre-Market Session
2 months ago - By: Vera Therapeutics
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Vera Therapeutics
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 months ago - By: Yahoo Finance
- Mentions:
VAC
Millions in Insider Buying Point to These 2 Stocks — Here’s What It Could Signal
3 months ago - By: MarketBeat
- Mentions:
KYMR
RAPP
SNY
Analysts Can't Get Enough of These Little-Known Biopharma Stocks
3 months ago - By: Vera Therapeutics
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Vera Therapeutics
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Yahoo Finance
- Mentions:
SRPT
ALNY
AKBA
PLTR
...
The FDA granted Sarepta’s rAAVrh74 Viral Vector a Platform Technology Designation
3 months ago - By: Vera Therapeutics
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
3 months ago - By: Vera Therapeutics
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
3 months ago - By: Stocktwits
- Mentions:
VTI
IWM
Vera Therapeutics Enters $500M Credit Facility As It Nears FDA Filing For Kidney Disease Drug: Retail Sees Stock Touching $40
3 months ago - By: Vera Therapeutics
Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans
3 months ago - By: Vera Therapeutics
Vera Therapeutics Announces Refinancing of Existing Oxford Debt Facility, Providing up to $500 Million of Term Loans
Please enable JavaScript to continue using this application.